Barclays’s Denali Therapeutics DNLI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $1M | Sell |
52,084
-355,275
| -87% | -$7.07M | ﹤0.01% | 2764 |
|
|
2025
Q4 | $6.73M | Sell |
407,359
-29,642
| -7% | -$500K | ﹤0.01% | 1985 |
|
|
2025
Q3 | $6.35M | Buy |
437,001
+11,020
| +3% | +$158K | ﹤0.01% | 2011 |
|
|
2025
Q2 | $5.96M | Buy |
425,981
+185,333
| +77% | +$2.61M | ﹤0.01% | 1974 |
|
|
2025
Q1 | $3.27M | Sell |
240,648
-37,419
| -13% | -$717K | ﹤0.01% | 2257 |
|
|
2024
Q4 | $5.67M | Buy |
278,067
+22,184
| +9% | +$568K | ﹤0.01% | 2036 |
|
|
2024
Q3 | $7.45M | Buy |
255,883
+128,823
| +101% | +$3.19M | ﹤0.01% | 1705 |
|
|
2024
Q2 | $2.95M | Sell |
127,060
-24,500
| -16% | -$470K | ﹤0.01% | 1865 |
|
|
2024
Q1 | $3.11M | Sell |
151,560
-172,459
| -53% | -$3.24M | ﹤0.01% | 2196 |
|
|
2023
Q4 | $6.95M | Buy |
324,019
+157,512
| +95% | +$3.12M | ﹤0.01% | 1817 |
|
|
2023
Q3 | $3.44M | Buy |
166,507
+8,045
| +5% | +$204K | ﹤0.01% | 1551 |
|
|
2023
Q2 | $4.68M | Sell |
158,462
-497,965
| -76% | -$14M | ﹤0.01% | 1386 |
|
|
2023
Q1 | $15.1M | Buy |
656,427
+70,462
| +12% | +$1.94M | 0.02% | 975 |
|
|
2022
Q4 | $16.3M | Buy |
585,965
+260,498
| +80% | +$7.75M | 0.01% | 986 |
|
|
2022
Q3 | $9.99M | Sell |
325,467
-43,304
| -12% | -$1.41M | 0.01% | 856 |
|
|
2022
Q2 | $10.9M | Buy |
368,771
+310,639
| +534% | +$8.14M | 0.01% | 977 |
|
|
2022
Q1 | $1.87M | Sell |
58,132
-62,689
| -52% | -$2.16M | ﹤0.01% | 1914 |
|
|
2021
Q4 | $5.39M | Buy |
120,821
+49,856
| +70% | +$2.36M | ﹤0.01% | 1653 |
|
|
2021
Q3 | $3.58M | Buy |
70,965
+47,204
| +199% | +$2.66M | ﹤0.01% | 1859 |
|
|
2021
Q2 | $1.86M | Sell |
23,761
-66,012
| -74% | -$4.08M | ﹤0.01% | 2244 |
|
|
2021
Q1 | $5.13M | Buy |
89,773
+67,315
| +300% | +$4.51M | ﹤0.01% | 1499 |
|
|
2020
Q4 | $1.88M | Sell |
22,458
-6,356
| -22% | -$384K | ﹤0.01% | 2277 |
|
|
2020
Q3 | $1.03M | Sell |
28,814
-6,775
| -19% | -$204K | ﹤0.01% | 2663 |
|
|
2020
Q2 | $860K | Buy |
35,589
+17,619
| +98% | +$414K | ﹤0.01% | 2889 |
|
|
2020
Q1 | $314K | Sell |
17,970
-30,698
| -63% | -$640K | ﹤0.01% | 3962 |
|
|
2019
Q4 | $848K | Buy |
48,668
+4,218
| +9% | +$70.2K | ﹤0.01% | 3824 |
|
|
2019
Q3 | $681K | Buy |
44,450
+13,538
| +44% | +$259K | ﹤0.01% | 3985 |
|
|
2019
Q2 | $642K | Buy |
30,912
+17,184
| +125% | +$385K | ﹤0.01% | 4104 |
|
|
2019
Q1 | $319K | Buy |
+13,728
| New | +$287K | ﹤0.01% | 4478 |
|
|
2018
Q4 | – | Sell |
-17,071
| Closed | -$371K | – | 7017 |
|
|
2018
Q3 | $371K | Buy |
17,071
+15,833
| +1,279% | +$262K | ﹤0.01% | 4510 |
|
|
2018
Q2 | $19K | Sell |
1,238
-2,099
| -63% | -$39.6K | ﹤0.01% | 6210 |
|
|
2018
Q1 | $65K | Buy |
+3,337
| New | +$68.6K | ﹤0.01% | 5685 |
|
Other funds holding DNLI
VCM
VPM
